Open AccessLong-term treatment outcomes of clevudine in antiviral-naive patients with chronic hepatitis B
Author(s) -
Suk Bae Kim,
Il Han Song,
Young Min Kim,
Ran Noh,
Ha Yan Kang,
Hyang Ie Lee,
Hyeon Yoong Yang,
An Na Kim,
Hee Bok Chae,
Sae Hwan Lee,
Hong Soo Kim,
Tae Hee Lee,
Young Woo Kang,
Eaum Seok Lee,
Seok Hyun Kim,
Byung Seok Lee,
Heon Young Lee
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i47.6943
Subject(s) - entecavir , medicine , hbeag , seroconversion , gastroenterology , titer , hepatitis b virus , serology , hepatitis b , virology , immunology , hbsag , virus , lamivudine , antibody
To evaluate the treatment outcomes of clevudine compared with entecavir in antiviral-naive patients with chronic hepatitis B (CHB).